company background image

Apontis Pharma DB:APPH Stock Report

Last Price


Market Cap







30 Sep, 2023


Company Financials +

Apontis Pharma AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Apontis Pharma
Historical stock prices
Current Share Price€4.11
52 Week High€12.05
52 Week Low€4.11
1 Month Change-17.80%
3 Month Change-49.38%
1 Year Change-38.84%
3 Year Changen/a
5 Year Changen/a
Change since IPO-78.20%

Recent News & Updates

Recent updates

Shareholder Returns

APPHDE PharmaceuticalsDE Market

Return vs Industry: APPH underperformed the German Pharmaceuticals industry which returned -4.7% over the past year.

Return vs Market: APPH underperformed the German Market which returned 16.1% over the past year.

Price Volatility

Is APPH's price volatile compared to industry and market?
APPH volatility
APPH Average Weekly Movement12.7%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement4.4%
10% most volatile stocks in DE Market8.6%
10% least volatile stocks in DE Market2.2%

Stable Share Price: APPH is more volatile than 90% of German stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: APPH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

1946168Bruno Wohlschlegel

Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.

Apontis Pharma AG Fundamentals Summary

How do Apontis Pharma's earnings and revenue compare to its market cap?
APPH fundamental statistics
Market Cap€36.65m
Earnings (TTM)-€3.18m
Revenue (TTM)€46.13m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
APPH income statement (TTM)
Cost of Revenue€16.79m
Gross Profit€29.34m
Other Expenses€32.52m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date


Earnings per share (EPS)-0.38
Gross Margin63.60%
Net Profit Margin-6.90%
Debt/Equity Ratio0%

How did APPH perform over the long term?

See historical performance and comparison